DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
DIAMTHAZOLE DIHYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
DIAMTHAZOLE DIHYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
3LF09TBB5W
Molecule Type:
Small molecule
Molecular Formula:
C15H25Cl2N3OS
Molecular Weight:
366.36
AlogP:
3.08
PSA:
28.6
HBD:
0.0
HBA:
#RotB:
7.0
Source:
SISOMICIN
4
Small molecule
Approved
Unknown
Unknown
Bacterial Infections
Bacterial 70S ribosome inhibitor
SISOMICIN
×
Maximum Phase:
4
First Approval:
None
UNII:
X55XSL74YQ
Molecule Type:
Small molecule
Molecular Formula:
C19H37N5O7
Molecular Weight:
447.53
AlogP:
-3.85
PSA:
213.72
HBD:
8.0
HBA:
#RotB:
6.0
Source:
PIRARUBICIN
4
Small molecule
Approved
Unknown
Unknown
Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma; Breast Neoplasms; Carcinoma, Hepatocellular; Neoplasms
Unknown
PIRARUBICIN
×
Maximum Phase:
4
First Approval:
None
UNII:
D58G680W0G
Molecule Type:
Small molecule
Molecular Formula:
C32H37NO12
Molecular Weight:
627.64
AlogP:
1.55
PSA:
204.3
HBD:
5.0
HBA:
#RotB:
7.0
Source:
TECHNETIUM TC 99M ARCITUMOMAB
4
Antibody
Approved
Unknown
Unknown
Unknown
Unknown
TECHNETIUM TC 99M ARCITUMOMAB
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DISTIGMINE BROMIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
DISTIGMINE BROMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
750F36OP6J
Molecule Type:
Small molecule
Molecular Formula:
C22H32Br2N4O4
Molecular Weight:
576.33
AlogP:
2.46
PSA:
66.84
HBD:
0.0
HBA:
#RotB:
9.0
Source:
EPOETIN ALFA-EPBX
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
EPOETIN ALFA-EPBX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLUTICASONE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
FLUTICASONE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LOPERAMIDE HYDROCHLORIDE; SIMETHICONE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
LOPERAMIDE HYDROCHLORIDE; SIMETHICONE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BETADINE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
BETADINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MISTLETOE EXTRACT
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
MISTLETOE EXTRACT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEXENONE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
MEXENONE
×
Maximum Phase:
4
First Approval:
None
UNII:
ET1UGF4A0B
Molecule Type:
Small molecule
Molecular Formula:
C15H14O3
Molecular Weight:
242.27
AlogP:
2.94
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
3.0
Source:
ZITHROMAX
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ZITHROMAX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLOROQUINE PHOSPHATE; PRIMAQUINE PHOSPHATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLOROQUINE PHOSPHATE; PRIMAQUINE PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MENTHOL; METHYL SALICYLATE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
MENTHOL; METHYL SALICYLATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA
4
Protein
Unknown
Unknown
Unknown
Kidney Diseases; Anemia; Renal Insufficiency, Chronic
Erythropoietin receptor agonist
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA
×
Maximum Phase:
4
First Approval:
None
UNII:
LR3UXN0193
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMLODIPINE BESYLATE; TELMISARTAN
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
AMLODIPINE BESYLATE; TELMISARTAN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASPIRIN; CAFFEINE; PROPOXYPHENE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ASPIRIN; CAFFEINE; PROPOXYPHENE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
METHYLPREDNISOLONE ACETATE; NEOMYCIN SULFATE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
METHYLPREDNISOLONE ACETATE; NEOMYCIN SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIOVANCE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
BIOVANCE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INDALPINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Serotonin transporter inhibitor
INDALPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
V35562QSVT
Molecule Type:
Small molecule
Molecular Formula:
C15H20N2
Molecular Weight:
228.34
AlogP:
3.1
PSA:
27.82
HBD:
2.0
HBA:
#RotB:
3.0
Source:
AMINOPYRINE
4
Small molecule
Approved
Unknown
Unknown
Fever; Pain
Unknown
AMINOPYRINE
×
Maximum Phase:
4
First Approval:
None
UNII:
01704YP3MO
Molecule Type:
Small molecule
Molecular Formula:
C13H17N3O
Molecular Weight:
231.3
AlogP:
1.55
PSA:
30.17
HBD:
0.0
HBA:
#RotB:
2.0
Source:
INSULIN GLARGINE-YFGN
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
INSULIN GLARGINE-YFGN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IPODATE CALCIUM
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
IPODATE CALCIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
50S7W5M9ZZ
Molecule Type:
Small molecule
Molecular Formula:
C24H24CaI6N4O4
Molecular Weight:
1233.98
AlogP:
3.74
PSA:
52.9
HBD:
1.0
HBA:
#RotB:
5.0
Source:
IL-2
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
IL-2
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAUROLIDINE
4
Small molecule
Approved
Unknown
Unknown
Central Nervous System Neoplasms; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Infections
Unknown
TAUROLIDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
8OBZ1M4V3V
Molecule Type:
Small molecule
Molecular Formula:
C7H16N4O4S2
Molecular Weight:
284.36
AlogP:
-2.67
PSA:
98.82
HBD:
2.0
HBA:
#RotB:
2.0
Source:
BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM
4
Combination
Approved
Unknown
OPHTHALMIC
Unknown
Unknown
BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TECHNETIUM TC-99M POLYPHOSPHATE KIT
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
TECHNETIUM TC-99M POLYPHOSPHATE KIT
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FORMOTEROL FUMARATE; MOMETASONE FUROATE
4
Combination
Approved
OTHER; PEDIATRICS; RESPIRATORY
INHALATION
Unknown
Unknown
FORMOTEROL FUMARATE; MOMETASONE FUROATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE
4
Combination
Approved
Unknown
INHALATION
Unknown
Unknown
OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEXFENFLURAMINE HYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Serotonin (5-HT) receptor agonist
DEXFENFLURAMINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
PM28L0FHNP
Molecule Type:
Small molecule
Molecular Formula:
C12H17ClF3N
Molecular Weight:
267.72
AlogP:
3.25
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
4.0
Source:
CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CALCIUM DOBESILATE
4
Small molecule
Approved
Unknown
Unknown
Rosacea; Diabetes Mellitus, Type 2; Infertility; Menorrhagia; Varicose Veins
Unknown
CALCIUM DOBESILATE
×
Maximum Phase:
4
First Approval:
None
UNII:
5921X1560Q
Molecule Type:
Small molecule
Molecular Formula:
C12H10CaO10S2
Molecular Weight:
418.41
AlogP:
0.34
PSA:
94.83
HBD:
3.0
HBA:
#RotB:
1.0
Source:
CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
273
274
275
276
277
278
279
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA